학술논문
Efficacy and safety of octanorm (cutaquig® ) in adults with primary immunodeficiencies with predominant antibody deficiency: A prospective, open-label study
Document Type
Article
Source
In: Immunotherapy . (Immunotherapy, April 2020, 12(5):299-309)
Subject
Language
English
ISSN
17507448
1750743X
1750743X